Professor Sun Myint
Clatterbridge Cancer Centre (Private Clinic)
Professor Sun Myint introduced Papillon in 1993 and established the first facility in the UK at Clatterbridge Cancer Centre. He has now treated over 1600 patients with Papillon which is the world largest cohort treated by non-surgical method. He collaborated with his mentor Prof Jean Pierre Gerard (Nice) and Ariane a British company to produce a new contact X-ray machine. Since 2009 he used the first prototype Papillon 50. He is now working closely with Ariane to produce a second generation Papillon Plus machine which can treat other tumour sites such as breast, skin, eye, intra oral, intra vagina and intra operative radiation therapy.
NICE has now approved the Papillon treatment for rectal cancer in patients not suitable for surgery (IPG 532). For his contributions to oncology, he was awarded Honorary Professor by University of Liverpool in 2012. He led the UK Papillon team which won the prestigious BMJ award for ‘Cancer team of the year’ in May 2018.
Rectal cancer- Do patients have a choice?
Each year 12,000 patients are diagnosed with rectal cancer in the UK. The standard of care is radical surgery. Not all patients are suitable for surgery due to advancing age and their comorbidities. The mortality and morbidity is high following surgery in elderly patients. There is increase in ageing population in the UK. Contact X-ray brachytherapy[CXB] (Papillon) will be discuss as an alternative non-surgical treatment option for patients not suitable for surgery.
EVEN MORE SEMINARS
Dr. Anna ME Bruynzeel Amsterdam UMC (formerly VUmc)
MR Guided Adaptive Radiation Therapy; three years of clinical experience at VUmc
DR Zayad Ratansi o3 Health Ltd
Hyperbarics within Oncology
Luca Boldrini Università Cattolica del Sacro Cuore, Roma, Italia
Radiomics applications rectal cancer: the MRIdian perspective
Professor Farzin Farzaneh King’s College London
Advanced Therapy Medicinal Products (ATMPs) for achievement of deeper and longer lasting immune mediated cancer remission
Dr. Matthew Prime Roche Diagnostics Information Solutions
Personalized healthcare: Leveraging data to improve patient care through clinical decision support in oncology